MD1838G2 - Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice - Google Patents

Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice Download PDF

Info

Publication number
MD1838G2
MD1838G2 MD97-0052A MD970052A MD1838G2 MD 1838 G2 MD1838 G2 MD 1838G2 MD 970052 A MD970052 A MD 970052A MD 1838 G2 MD1838 G2 MD 1838G2
Authority
MD
Moldova
Prior art keywords
dichlorbenzimidazole
prevention
derivatives
obtaining
treatment
Prior art date
Application number
MD97-0052A
Other languages
English (en)
Russian (ru)
Other versions
MD1838F2 (ro
Inventor
Стэнли Дейвс ЧАМБЕРЛАЙН
Георге Уолтер КОСЗАЛКА
Original Assignee
Зэ Уелкэм Фаундейшэн Лимитид
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зэ Уелкэм Фаундейшэн Лимитид filed Critical Зэ Уелкэм Фаундейшэн Лимитид
Publication of MD1838F2 publication Critical patent/MD1838F2/ro
Publication of MD1838G2 publication Critical patent/MD1838G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Invenţia se referă la derivaţii de 5,6-diclorbenzimidazol cu formula (I)(I)în care substituenţii au semnificaţia indicată în descriere.De asemenea se revendică procedeul de obţinere a lor, compoziţia farmaceutică şi metoda de tratament sau de prevenire a simptomelor infecţiei virotice herpetice.
MD97-0052A 1994-07-07 1995-07-06 Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice MD1838G2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413724A GB9413724D0 (en) 1994-07-07 1994-07-07 Therapeutic nucleosides
PCT/GB1995/001597 WO1996001833A1 (en) 1994-07-07 1995-07-06 Therapeutic compounds

Publications (2)

Publication Number Publication Date
MD1838F2 MD1838F2 (ro) 2002-01-31
MD1838G2 true MD1838G2 (ro) 2002-08-31

Family

ID=10757983

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0052A MD1838G2 (ro) 1994-07-07 1995-07-06 Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice

Country Status (43)

Country Link
US (4) US6077832A (ro)
EP (1) EP0769017B1 (ro)
JP (1) JP3225045B2 (ro)
KR (1) KR100376075B1 (ro)
CN (2) CN1052010C (ro)
AP (1) AP736A (ro)
AT (1) ATE193298T1 (ro)
AU (1) AU702248B2 (ro)
BG (1) BG63435B1 (ro)
BR (1) BR9508237A (ro)
CY (1) CY2249B1 (ro)
CZ (1) CZ290800B6 (ro)
DE (1) DE69517172T2 (ro)
DK (1) DK0769017T3 (ro)
EE (1) EE03568B1 (ro)
ES (1) ES2147294T3 (ro)
FI (1) FI117629B (ro)
GB (1) GB9413724D0 (ro)
GE (1) GEP20002298B (ro)
GR (1) GR3033744T3 (ro)
HR (1) HRP950382B1 (ro)
HU (1) HU227679B1 (ro)
IL (1) IL114492A (ro)
IS (1) IS1812B (ro)
MD (1) MD1838G2 (ro)
MX (1) MX9606732A (ro)
MY (1) MY117892A (ro)
NO (1) NO308854B1 (ro)
NZ (1) NZ288722A (ro)
OA (1) OA10339A (ro)
PL (1) PL181136B1 (ro)
PT (1) PT769017E (ro)
RO (1) RO117699B1 (ro)
RU (1) RU2145963C1 (ro)
SA (1) SA95160202B1 (ro)
SK (1) SK282046B6 (ro)
TJ (1) TJ270B (ro)
TR (1) TR199500832A2 (ro)
TW (1) TW418196B (ro)
UA (1) UA66744C2 (ro)
WO (1) WO1996001833A1 (ro)
YU (1) YU49443B (ro)
ZA (1) ZA955644B (ro)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
ATE227734T1 (de) * 1995-08-18 2002-11-15 Univ Michigan 5'-substitutierte-ribofuranosyl benzimidazolen als antivirale.
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
JP2001501580A (ja) 1996-01-23 2001-02-06 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 抗ウイルス剤としての修飾ベンズイミダゾールヌクレオシド
US6576133B2 (en) 1996-11-13 2003-06-10 Transgenomic, Inc Method and system for RNA analysis by matched ion polynucleotide chromatography
US6475388B1 (en) 1996-11-13 2002-11-05 Transgenomic, Inc. Method and system for RNA analysis by matched ion polynucleotide chromatography
GB2319961A (en) * 1996-12-07 1998-06-10 Glaxo Group Ltd Pharmaceutical composition for treatment of restenosis
CA2280761A1 (en) 1997-02-13 1998-08-20 Stanley Dawes Chamberlain Benzimidazole derivatives
EA002305B1 (ru) 1997-06-10 2002-02-28 Глэксо Гроуп Лимитед Производные бензимидазола
WO1999006424A1 (en) 1997-07-30 1999-02-11 The Regents Of The University Of Michigan Lyxofuranosyl benzimidazoles as antiviral agents
US6258264B1 (en) 1998-04-10 2001-07-10 Transgenomic, Inc. Non-polar media for polynucleotide separations
GB9807355D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
US6277830B1 (en) * 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
RU2262344C2 (ru) * 2001-07-25 2005-10-20 Дж.Б.Кемикалс Энд Фармасьютикалс Лтд. Фармацевтическая композиция для лечения кожных инфекций и способ ее получения
RU2366661C2 (ru) * 2002-06-28 2009-09-10 Айденикс (Кайман) Лимитед Пролекарства модифицированных 2'- и 3'-нуклеозидов для лечения инфекций flaviviridae
CA2530490A1 (en) 2003-06-25 2005-01-13 Stephen F. Badylak Conditioned matrix compositions for tissue restoration
JP4914611B2 (ja) * 2003-12-26 2012-04-11 キッセイ薬品工業株式会社 ベンズイミダゾール誘導体及びその医薬用途
RU2268741C1 (ru) * 2004-08-04 2006-01-27 Государственное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" Способ лечения герпетического поражения вестибулярного, спирального, тригеминального и коленчатого ганглиев
JPWO2006115137A1 (ja) * 2005-04-22 2008-12-18 キッセイ薬品工業株式会社 ２−アミノベンズイミダゾール誘導体及びその医薬用途
EA008737B1 (ru) * 2005-12-07 2007-08-31 Леонид Андреевич Кожемякин Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US8940707B2 (en) * 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
US8541391B2 (en) 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
US9447050B2 (en) 2011-04-05 2016-09-20 The Translational Genomics Research Institute Solid forms of curcumin
WO2014004939A1 (en) 2012-06-29 2014-01-03 The Procter & Gamble Company Textured fibrous webs, apparatus and methods for forming textured fibrous webs
EP2970277B1 (en) 2013-03-15 2021-07-28 Knopp Biosciences LLC Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
SMT202300362T1 (it) 2014-09-12 2023-11-13 Biohaven Therapeutics Ltd Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7
WO2016086060A1 (en) * 2014-11-26 2016-06-02 The J. David Gladstone Institutes Methods for treating a cytomegalovirus infection
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
CA3093976A1 (en) 2018-03-19 2019-09-26 Michael E. Bozik Kv7 channel activators compositions and methods of use
JP7376108B2 (ja) * 2020-06-23 2023-11-08 バイオメトリックス テクノロジーズ インコーポレイテッド 新規なベンズイミダゾール誘導体、その製造方法及びその抗癌剤または抗ウイルス剤としての用途
EP4480956A3 (en) 2022-10-12 2025-02-19 Takeda Pharmaceutical Company Limited Viral inhibitors, the synthesis thereof, and intermediates thereto
WO2024103979A1 (zh) * 2022-11-17 2024-05-23 北京凯因科技股份有限公司 一种抑制疱疹病毒的化合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007867A1 (en) * 1990-11-01 1992-05-14 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
WO1993018009A1 (en) * 1992-03-09 1993-09-16 The Wellcome Foundation Limited Antiviral nucleoside analogues
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) * 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) * 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
NL6716664A (ro) * 1966-12-19 1968-06-20
US3655901A (en) * 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) * 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
US4002623A (en) * 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2549938B1 (fr) * 1983-07-25 1987-08-07 Fonderie Soc Gen De Bruleur a premelange gazeux et chaudiere equipee d'un tel bruleur
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
CH667649A5 (en) * 1986-09-10 1988-10-31 Lonza Ag 2-Substd. amino-benzoxazole and -benzimidazole derivs. prodn. - by reacting prim. amino cpd. with amine in presence of acid catalyst, useful as intermediates e.g. for pharmaceuticals
EP0304624A3 (de) * 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
DE3924424A1 (de) * 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
EP0530407B1 (en) * 1991-09-04 1996-06-05 Stichting REGA V.Z.W. Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them
US5314903A (en) * 1991-12-03 1994-05-24 Neurosearch A/S Benzimidazole compounds useful as calcium channel blockers
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
JP6217655B2 (ja) * 2015-01-15 2017-10-25 トヨタ自動車株式会社 電力変換装置

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007867A1 (en) * 1990-11-01 1992-05-14 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
WO1993018009A1 (en) * 1992-03-09 1993-09-16 The Wellcome Foundation Limited Antiviral nucleoside analogues
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents

Also Published As

Publication number Publication date
EE9700013A (et) 1997-06-16
US5998605A (en) 1999-12-07
CZ290800B6 (cs) 2002-10-16
FI970032L (fi) 1997-01-03
SK168896A3 (en) 1997-09-10
SA95160202B1 (ar) 2005-04-16
FI117629B (fi) 2006-12-29
SK282046B6 (sk) 2001-10-08
CZ4097A3 (en) 1997-08-13
JPH10502356A (ja) 1998-03-03
HRP950382B1 (en) 2000-12-31
DE69517172T2 (de) 2000-10-19
HK1003711A1 (en) 1998-11-06
HU9700034D0 (en) 1997-02-28
ES2147294T3 (es) 2000-09-01
IS4394A (is) 1996-12-09
KR100376075B1 (ko) 2004-02-18
DK0769017T3 (da) 2000-09-11
ATE193298T1 (de) 2000-06-15
OA10339A (en) 1997-10-07
EP0769017B1 (en) 2000-05-24
CN1052010C (zh) 2000-05-03
NZ288722A (en) 1998-07-28
TW418196B (en) 2001-01-11
IL114492A (en) 2002-05-23
AU2805195A (en) 1996-02-09
HU227679B1 (en) 2011-11-28
GB9413724D0 (en) 1994-08-24
HRP950382A2 (en) 1997-08-31
JP3225045B2 (ja) 2001-11-05
BG101118A (en) 1998-04-30
EE03568B1 (et) 2001-12-17
US20010003744A1 (en) 2001-06-14
NO970040L (no) 1997-01-29
YU45095A (sh) 1999-03-04
UA66744C2 (en) 2004-06-15
TJ270B (en) 2000-08-07
PL318062A1 (en) 1997-05-12
RU2145963C1 (ru) 2000-02-27
GEP20002298B (en) 2000-11-25
RO117699B1 (ro) 2002-06-28
BG63435B1 (bg) 2002-01-31
YU49443B (sh) 2006-03-03
NO970040D0 (no) 1997-01-06
MX9606732A (es) 1997-04-30
MD1838F2 (ro) 2002-01-31
EP0769017A1 (en) 1997-04-23
MY117892A (en) 2004-08-30
IL114492A0 (en) 1995-11-27
GR3033744T3 (en) 2000-10-31
AP9600895A0 (en) 1997-01-31
PL181136B1 (pl) 2001-06-29
ZA955644B (en) 1997-01-06
CN1159194A (zh) 1997-09-10
CY2249B1 (en) 2003-07-04
WO1996001833A1 (en) 1996-01-25
TR199500832A2 (tr) 1996-06-21
US6077832A (en) 2000-06-20
BR9508237A (pt) 1999-06-01
FI970032A0 (fi) 1997-01-03
PT769017E (pt) 2000-09-29
AP736A (en) 1999-03-09
AU702248B2 (en) 1999-02-18
CN1236616A (zh) 1999-12-01
IS1812B (is) 2002-05-15
DE69517172D1 (de) 2000-06-29
NO308854B1 (no) 2000-11-06
US6307043B1 (en) 2001-10-23
HUT77285A (hu) 1998-03-30

Similar Documents

Publication Publication Date Title
MD1838G2 (ro) Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
AP9701041A0 (en) Pyridylpyrrole compounds.
PL367682A1 (en) Dolastatin 10 derivatives
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
IL111077A0 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
MY124122A (en) Heterocyclic derivatives
HUT62337A (en) New cyclosporins, pharmaceutical compositions comprising such compounds and process for producing same
CA2210258A1 (en) Substituted oxazolidine calpain and/or cathepsin b inhibitors
BG103947A (en) Derivatives of 9-oxymerythromycin
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
PL325339A1 (en) Derivatives of piperasine as neurokinin antagonists
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
CA2168447A1 (en) Compounds and methods for inhibition of hiv and related viruses
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
HUP9601321A3 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
ZA979647B (en) Heterocyclic compounds, compositions and uses.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
CA2114859A1 (en) Cytotoxic and antiviral compound
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
CA2263846A1 (en) Novel pyranoside derivatives

Legal Events

Date Code Title Description
MK4A Patent for invention expired